Cargando…

Selective Modulation of TNF–TNFRs Signaling: Insights for Multiple Sclerosis Treatment

Autoimmunity develops when self-tolerance mechanisms are failing to protect healthy tissue. A sustained reaction to self is generated, which includes the generation of effector cells and molecules that destroy tissues. A way to restore this intrinsic tolerance is through immune modulation that aims...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pegoretti, Valentina, Baron, Wia, Laman, Jon D., Eisel, Ulrich L. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5936749/ https://www.ncbi.nlm.nih.gov/pubmed/29760711 http://dx.doi.org/10.3389/fimmu.2018.00925

Ejemplares similares

Sequential treatment with a TNFR2 agonist and a TNFR1 antagonist improves outcomes in a humanized mouse model for MS
por: Pegoretti, Valentina, et al.
Publicado: (2023)

Inflammation and Oxidative Stress in Multiple Sclerosis: Consequences for Therapy Development
por: Pegoretti, Valentina, et al.
Publicado: (2020)

Modulation of Multiple Sclerosis and Its Animal Model Experimental Autoimmune Encephalomyelitis by Food and Gut Microbiota
por: van den Hoogen, Ward J., et al.
Publicado: (2017)

Drosophila TNFRs Grindelwald and Wengen bind Eiger with different affinities and promote distinct cellular functions
por: Palmerini, Valentina, et al.
Publicado: (2021)

LPS-Challenged TNFα Production, Prostaglandin Secretion, and TNFα/TNFRs Expression in the Endometrium of Domestic Cats in Estrus or Diestrus, and in Cats with Pyometra or Receiving Medroxyprogesterone Acetate
por: Jursza, Ewelina, et al.
Publicado: (2014)

The Primate EAE Model Points at EBV-Infected B Cells as a Preferential Therapy Target in Multiple Sclerosis
por: ‘T Hart, Bert A., et al.
Publicado: (2013)

The adenosinergic signaling in the pathogenesis and treatment of multiple sclerosis
por: Duarte-Silva, Eduardo, et al.
Publicado: (2022)

Teriflunomide Treatment of Multiple Sclerosis Selectively Modulates CD8 Memory T Cells
por: Tilly, Gaëlle, et al.
Publicado: (2021)

A B Cell-Driven Autoimmune Pathway Leading to Pathological Hallmarks of Progressive Multiple Sclerosis in the Marmoset Experimental Autoimmune Encephalomyelitis Model
por: ’t Hart, Bert A., et al.
Publicado: (2017)

Targeting Fibronectin to Overcome Remyelination Failure in Multiple Sclerosis: The Need for Brain- and Lesion-Targeted Drug Delivery
por: van Schaik, Pauline E. M., et al.
Publicado: (2022)

The emerging role of galectins in (re)myelination and its potential for developing new approaches to treat multiple sclerosis
por: de Jong, Charlotte G. H. M., et al.
Publicado: (2019)

9. Successful use of IL-6 pathway blockade to treat autoinflammation occurring in the context of a novel TNFRS1A gene mutation
por: Dyke, Bernard, et al.
Publicado: (2019)

Immunological and Clinical Effect of Diet Modulation of the Gut Microbiome in Multiple Sclerosis Patients: A Pilot Study
por: Saresella, Marina, et al.
Publicado: (2017)

Targeting senescence to delay progression of multiple sclerosis
por: Oost, Wendy, et al.
Publicado: (2018)

Role of TNF–TNF Receptor 2 Signal in Regulatory T Cells and Its Therapeutic Implications
por: Yang, Sujuan, et al.
Publicado: (2018)

B Cells Are Multifunctional Players in Multiple Sclerosis Pathogenesis: Insights from Therapeutic Interventions
por: Claes, Nele, et al.
Publicado: (2015)

Modulation of P2X7 Receptor during Inflammation in Multiple Sclerosis
por: Amadio, Susanna, et al.
Publicado: (2017)

The benefits of clustering in TNF receptor superfamily signaling
por: Vanamee, Éva S., et al.
Publicado: (2023)

CD40 in Clinical Inflammation: From Multiple Sclerosis to Atherosclerosis
por: Laman, Jon D., et al.
Publicado: (1998)

Treatment-Induced BAFF Expression and B Cell Biology in Multiple Sclerosis
por: Smets, Ide, et al.
Publicado: (2021)

TNFα-Signaling Modulates the Kinase Activity of Human Effector Treg and Regulates IL-17A Expression
por: Urbano, Paulo C. M., et al.
Publicado: (2020)

TNF-Signaling Modulates Neutrophil-Mediated Immunity at the Feto-Maternal Interface During LPS-Induced Intrauterine Inflammation
por: Presicce, Pietro, et al.
Publicado: (2020)

Nutritional and ecological perspectives of the interrelationships between diet and the gut microbiome in multiple sclerosis: Insights from marmosets
por: Perez-Muñoz, Maria Elisa, et al.
Publicado: (2021)

Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis
por: Gentile, Antonietta, et al.
Publicado: (2019)

Selective Brain Network and Cellular Responses Upon Dimethyl Fumarate Immunomodulation in Multiple Sclerosis
por: Ciolac, Dumitru, et al.
Publicado: (2019)

Could Mucosal TNF Transcript as a Biomarker Candidate Help Optimize Anti-TNF Biological Therapy in Patients With Ulcerative Colitis?
por: Cui, Guanglin, et al.
Publicado: (2022)

Editorial: Multiple Sclerosis – From Bench to Bedside: Currents Insights Into Pathophysiological Concepts and Their Potential Impact on Patients
por: Rommer, Paulus S., et al.
Publicado: (2020)

Astrocytes and Inflammatory T Helper Cells: A Dangerous Liaison in Multiple Sclerosis
por: Kunkl, Martina, et al.
Publicado: (2022)

Multiple sclerosis is linked to MAPK(ERK) overactivity in microglia
por: ten Bosch, George J. A., et al.
Publicado: (2021)

The Role of Astrocytes in Multiple Sclerosis
por: Ponath, Gerald, et al.
Publicado: (2018)

The Cerebrospinal Fluid in Multiple Sclerosis
por: Deisenhammer, Florian, et al.
Publicado: (2019)

Digital Twins for Multiple Sclerosis
por: Voigt, Isabel, et al.
Publicado: (2021)

Rehabilitation treatment of multiple sclerosis
por: Duan, Haoyang, et al.
Publicado: (2023)

Risk for Cardiovascular Adverse Events Associated With Sphingosine-1-Phosphate Receptor Modulators in Patients With Multiple Sclerosis: Insights From a Pooled Analysis of 15 Randomised Controlled Trials
por: Zhao, Zhao, et al.
Publicado: (2021)

The dichotomous outcomes of TNFα signaling in CD4(+) T cells
por: Skartsis, Nikolaos, et al.
Publicado: (2022)

Identification of a novel role for matrix metalloproteinase-3 in the modulation of B cell responses in multiple sclerosis
por: Chunder, Rittika, et al.
Publicado: (2022)

Effector T Helper Cells Are Selectively Controlled During Pregnancy and Related to a Postpartum Relapse in Multiple Sclerosis
por: Koetzier, Steven C., et al.
Publicado: (2021)

Pathological ultrastructural alterations of myelinated axons in normal appearing white matter in progressive multiple sclerosis
por: Oost, Wendy, et al.
Publicado: (2023)

Body Mass Index, Interleukin-6 Signaling and Multiple Sclerosis: A Mendelian Randomization Study
por: Vandebergh, Marijne, et al.
Publicado: (2022)

Anti-TNF-α agents Modulate SARS-CoV-2 Receptors and Increase the Risk of Infection Through Notch-1 Signaling
por: Keewan, Esra’a, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cq7f4j9nog5oebg3902vo5a8n3